These other reported observations may have weakened Nogo-A's potential as an ALS-specific marker [51, 57], and the merit of Nogo-A's diagnostic/prognostic value in ALS awaits further confirmation with larger clinical cohorts. The gene discussed is RTN4; the disease is amyotrophic lateral sclerosis.